# Alzheimer's Disease THErapy With NEuroaid II

> **NCT07191028** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Moleac Pte Ltd.** · enrollment: 350 (estimated)

## Conditions studied

- Alzheimer's Disease Dementia

## Interventions

- **DRUG:** MLC 901
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07191028
- **Lead sponsor:** Moleac Pte Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2025-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07191028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07191028, "Alzheimer's Disease THErapy With NEuroaid II". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07191028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*